Anthony P. Bihl III - Apr 10, 2023 Form 4 Insider Report for Bioventus Inc. (BVS)

Role
Interim CEO, Director
Signature
/s/Anthony D'Adamio, Attorney-in-Fact
Stock symbol
BVS
Transactions as of
Apr 10, 2023
Transactions value $
$0
Form type
4
Date filed
4/12/2023, 08:26 PM
Previous filing
Apr 10, 2023
Next filing
May 24, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BVS Restricted Stock Units Award $0 +76K $0.00 76K Apr 10, 2023 Class A Common Stock 76K Direct F1, F2
transaction BVS Stock Option (Right to Buy) Award $0 +198K $0.00 198K Apr 10, 2023 Class A Common Stock 198K $1.16 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F2 The RSUs and options, as applicable, vest on April 10, 2024.